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Abstract 
With the increasing movement away from the mouse bioassay for the detection of toxins in 
commercially harvested shellfish, there is a growing demand for the development of new and 
potentially field-deployable tests in its place. In this direction we report the development of a 
simple and sensitive nanoparticle-based luminescence technique for the detection of the 
marine biotoxin okadaic acid. Photoluminescent lanthanide nanoparticles were conjugated 
with fluorophore-labelled anti-okadaic acid antibodies which, upon binding to okadaic acid, 
gave rise to luminescence resonance energy transfer from the nanoparticle to the organic 
fluorophore dye deriving from a reduction in distance between the two. The intensity ratio of 
the fluorophore : nanoparticle emission peaks was found to correlate with okadaic acid 
concentration, and the sensor showed a linear response in the 0.37–3.97 μM okadaic acid 
range with a limit of detection of 0.25 μM.  This work may have important implications for 
the development of new, cheap and versatile biosensors for a range of biomolecules and that 
are sufficiently simple to be applied in the field or at point-of-care. 
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Introduction 
Okadaic acid (9,10-Deepithio-9,10-didehydroacanthifolicin), an ionophore-like poly-
ether derivative of a 38 carbon fatty acid, is an important molecule widely used in studies of 
cell growth and functioning as it is a potent serine/threonine protein phosphatase 2A inhibitor 
[1], [2] and [3]. Apart from its cytotoxicity and being a tumor promoter, okadaic acid also 
presents other risks to human health through direct ingestion. This lipophilic cyclic polyether 
is widely produced in the marine environment by dinoflagellates and is introduced into the 
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food chain through accumulation in shellfish which, upon consumption, results in diarrhetic 
shellfish poisoning [4]. The current reference method used to test for okadaic acid and other 
marine biotoxins is the mouse bioassay, a controversial method as results may be equivocal, 
suffers from low sensitivity and specificity, and ends with the death of the animal.  Thus, the 
European Union and the World Health Organization have directed that the use of laboratory 
animals be phased out with a call for states to improve and validate new toxin detection 
methods in shellfish [5] and [6]. However, as the okadaic acid acute reference dose is three to 
four times lower than the current regulatory limit of 160 µg kg-1, expected future reductions in 
the latter will also require more sensitive analytical techniques to be developed as the 
detection limit of such techniques must be several times lower than any new regulatory limit 
[7]. While the enzyme linked immunosorbent assay (ELISA) has proven a sensitive technique 
for the detection of okadaic acid, the technique gives equal weight to toxin congeners even 
though their toxic potential may be different [8]. Alternatively, the development of the protein 
phosphatase inhibition assay allows the determination of total potential toxicity although the 
method is non-specific and cross-reactivity with toxin variants can occur [9]. Liquid 
chromatography has provided a reliable, standardized method although is limited by being 
restricted to a few reference laboratories, is expensive and the requirement of extensive 
preparatory work such as the derivatization of toxins and method calibration significantly 
increases the amount of time needed for samples to be analyzed [10]. 
 
While all techniques offer both advantages and disadvantages, they are generally 
characterized by low throughput hence there is increasing interest in developing biosensor-
based approaches as they offer a solution to current drawbacks in terms of simplicity, speed 
and cost and ultimately may be used for analysis on-site [11] and [12]. In this direction, a 
number of approaches have been developed, including electrochemical immunosensors [13] 
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and [14], kinetic exclusion assays [15], chemiluminescence immunosensors [16] and surface 
plasmon resonance-based immunoassays [17]. As an alternative path, taking advantage of the 
unique optical properties of nanoscale materials may provide a new way in which to detect 
specific target molecules. A key technique which has been developed and applied extensively 
over the past two decades is Főrster resonance energy transfer (FRET), a mode which, by 
changes in spatial proximity between donor and acceptor complexes, allows non-radiative 
energy transfer between the two resulting in enhanced or reduced fluorescence emission at 
specific wavelengths. The extreme sensitivity of FRET to low target concentrations, and 
down to single molecules in cases, is already known [18]. 
 
Lanthanide ions have been gaining use over the past number of years, particularly in the 
form of chelates, as luminescent probes in biology due to their long excited-state lifetimes 
related to f-electron transitions which are well-shielded from external perturbations and do not 
participate greatly in chemical bonding [19] and [20]. As an extension of this, lanthanide ions 
encapsulated in nanoparticles may provide the same advantageous optical characteristics as 
chelates such as narrow excitation and emission lines and large Stokes shift, but with 
enhanced chemical stability, ease of synthesis and higher quantum yields than the organic 
fluorophores. Further, the long excited-state lifetimes enables time-resolved luminescence 
measurements which allow short-lived background fluorescence to be separated from the 
target signal [21], [22] and [23]. 
 
In the present work we show that lanthanide nanoparticles may be functionalized and 
applied to the detection of the environmental biotoxin okadaic acid by measurement of the 
emission of an acceptor organic dye following enhanced luminescence resonance energy 
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transfer (LRET) from the nanoparticle donor due to closer spatial proximity upon okadaic 
acid - anti-okadaic acid antibody binding.  
 
Experimental 
Materials 
All chemicals except for cerium nitrate were obtained from Sigma Aldrich at the 
highest purity available and were used as received. Cerium nitrate (≥99% p.a.) was supplied 
by Fluka, while rabbit polyclonal anti-okadaic acid antibodies and AlexaFluor488 goat anti-
rabbit labelling kit were supplied by Abcam (Cambridge, UK) and Life Technologies, 
respectively. A certified reference material comprising of blue mussel Mytilus edulis digestive 
gland tissue and a small amount of the dinoflagellate Prorocentrum lima containing 
10.1 µg g-1 okadaic acid was obtained from the National Research Council of Canada. 
 
Nanoparticle synthesis 
The synthesis of amino-functionalized cerium/terbium doped LaF3 nanoparticles 
followed the method of Diamente et al. [24] with some modifications. Briefly, a 2 mL 
aqueous solution of La(NO3)3·6H2O (1.26 mmol), Ce(NO3)3·6H2O (1.34 mmol) and 
Tb(NO3)3·6H2O (0.56 mmol) was added dropwise to a 25 mL aqueous solution of o-
phosphorylethanolamine (1 mmol; which had been initially neutralized by NH4OH) and NaF 
(3 mmol) at 40°C. The reaction was held at this temperature for 24 h upon which acetone was 
added to precipitate the nanoparticles. The nanoparticles were collected by centrifugation 
(4500 × g, 10 min.), washed with acetone and centrifuged again. 
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Nanoparticle functionalization 
Typically, for conjugation of anti-okadaic acid antibodies to lanthanide nanoparticles, 
5 μL rabbit serum containing IgG anti-okadaic acid antibodies was added to 1 mL borate 
buffer solution (pH 8.0, 0.05 M) in which 1 mg LaNP (~4 nM) had been previously dispersed 
and was gently mixed for 1 h at room temperature. To this solution was added 15 μL goat 
anti-rabbit IgG Fab fragment conjugated with AlexaFluor488 (AF) fluorophore and blocking 
reagents, and the solution was mixed for 1 h. Okadaic acid potassium salt (Mw=843.1 g mol-1) 
was dissolved in ultrapure water and added in 10 μL aliquots (100 ng aliquot-1) to the 
nanoparticle-antibody-Fab-AF solution to give a solution with increasing okadaic acid 
concentration. This solution was gently mixed at room temperature for 1 h upon which it was 
interrogated by fluorescence spectroscopy. 
 
Sensor validation 
The sensor was subsequently validated using a range of concentrations of okadaic acid 
extracted from certified shellfish tissue. Mussel tissue homogenate (50-300 mg) was extracted 
twice with 2 mL portions of 80% methanol, with the okadaic acid-containing methanol 
fraction separated from the homogenate by centrifugation (1000 × g, 10 min.) The volume 
was reduced to 100 μL by rotary evaporation upon which 900 μL of the sensor solution was 
added. The solutions were gently mixed for 10 min. followed by interrogation by fluorescence 
spectroscopy. (Note that contact with okadaic acid may induce nausea, vomiting and 
diarrhoea, thus requiring appropriate protective measures be taken.) 
 
Instrumental analysis 
Powder X-ray diffraction data were collected on a Rigaku Ultima IV multi-purpose 
diffractometer in parafocusing mode using Cu Kα radiation of wavelength 1.5418Å, 40 kV 
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tube voltage, 40mA current, scan speed of 1° min-1 (2θ) and step size of 0.02° (2θ). 
Divergence, receiving and scattering slits of ⅔°, ⅔° and 0.3 mm were used, while a Ni filter 
was employed to remove Kβ radiation with a 5º Soller slit for beam shape. Data processing 
was done on Rigaku PDXL 2.0 software. Dynamic light scattering data were collected on a 
Zetasizer Nano ZS (Malvern, UK) instrument equipped with a green laser (532 nm). Samples 
were suspended in borate buffer solution (pH 8.0, 0.05M) and were measured at 25ºC in 1 cm 
PMMA cuvettes. Intensity of scattered light was detected at the angle of 173º. Samples were 
interrogated a minimum of 10 times and data processing was carried out on proprietary 
Zetasizer software 6.32 (Malvern Instruments) with results reported as number size 
distributions and distribution widths. Atomic force micrographs were obtained on a 
Multimode AFM with Nanoscope IIIa controller (Bruker, Billerica USA) with a vertical 
engagement (JV) 125 μm scanner, in tapping mode using silicon tips (RTESP, Bruker, 
nominal tip radius 8 nm). Prior to imaging samples were sonicated for 15 min., diluted to 20 
µg  mL-1, and 5 μL of this suspension was pipeted directly onto freshly cleaved mica. Mica 
sheets were placed in enclosed Petri dishes for 15 min to allow samples to settle and adsorb to 
the surface and the surfaces were then rinsed three times with 50 μL ultrapure water and 
placed in enclosed Petri dishes. The excess of suspension was removed by absorption by 
laboratory paper. Processing and analysis of images was done on NanoScopeTM software 
(Digital Instruments, v.614r1). Scanning electron microscopy secondary electron images were 
recorded on a JEOL JSM 7000F instrument operating at an accelerating voltage of 10kV. 
Samples were prepared by allowing a drop of an aqueous dispersion of nanoparticles to 
gradually dry directly on the sample stub. Luminescence data were collected on a Cary 
Eclipse fluorescence spectrophotometer and Kontron SFM25 spectrofluorometer at room 
temperature using 1 cm optical path quartz cuvettes, with samples dispersed in borate buffer 
solution (pH 8, 0.05 M). Time resolved luminescence lifetime measurements were recorded 
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using the third harmonic of a 1 kHz laser system (Coherent Inc.), consisting of a Ti:SA 
oscillator (Mira Seed) and a Ti:SA amplifier (Legend), delivering an excitation pulse at 266 
nm at a laser repetition rate of 100 Hz. The excitation beam had a diameter of 300 μm at the 
position of the sample and its intensity was adjusted to 15 μW so that the fluorescence 
intensity of the nanoparticles lay within the linear regime. The samples had OD 0.6 at 266 
nm. The fluorescence was collected with a lens (f=150 mm) and focused to an amplified 
silicon photodiode (Thorlabs PDA36A-EC). The photodiode signal was acquired with a 
digital oscilloscope (Tektronix TDS3054B) that averaged out 512 shots. 
 
Results and Discussion 
Characterization of as-synthesized nanoparticles 
Powder X-ray diffraction data for the cerium/terbium doped lanthanide fluoride 
nanoparticles showed reflections consistent with hexagonal lanthanum fluoride (LaF3) and 
could be matched to the corresponding pattern in the database of the International Centre for 
Diffraction Data (card no. 00-008-0461; P63/mcm, a=7.184Å, c=7.351Å, α=90º, γ=120º), as 
shown in Figure 1. Crystallite sizes were determined by whole pattern fitting with pseudo-
Voigt shaped peaks and an average crystallite size of 2.1 nm was found by applying of the 
Scherrer formula to six main reflections. However, due to the broad reflections and relatively 
low signal-to-noise, the fitting of the raw data by simulation should be considered qualitative 
rather than quantitative. 
 
Decoration of nanoparticles 
Nanoparticle sizes determined by atomic force microscopy in tapping mode were found 
to range from about 10-30 nm with a calculated average size of 24±5 nm (n=40; Figure 2a). 
Very small particulates of ≤1 nm were also found to be present and are ascribed to the amine 
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ligand, a large excess of which had been used in the synthesis to ensure a crowded 
nanoparticle surface that promotes upright adsorption of the antibody by the hydrophobic Fc 
region. AFM imaging of the lanthanide nanoparticles conjugated to anti-okadaic acid 
antibodies showed larger entities with sizes typically in the range from 50-70 nm (Figure 2b) 
while imaging of antibodies alone showed sizes of about 3 nm (Figure 2c). 
 
Scanning electron microscopy images of nanoparticles and antibody-coated 
nanoparticles, respectively, are shown in Figure 3. Drying of samples prior to imaging 
resulted in a large degree of agglomeration, with undecorated nanoparticles forming clusters 
in the range of 0.5 – 1 μm (Figure 3a) and antibody-functionalized nanoparticles 
agglomerating into larger structures of 1 – 4 μm in diameter (Figure 3b). Surface morphology 
features are distinctly different between the as-synthesized and functionalized nanoparticles, 
with the latter showing a more indented surface likely related to the organic moieties residing 
on the surface that result in less symmetrical packing of nanoparticles during sample 
dehydration. 
 
Both as-synthesized and functionalized nanoparticles showed excellent stability in 
aqueous media and hydrodynamic diameters were determined by dynamic light scattering of 
solution-dispersed samples based on the peak maxima of the number size distributions, with 
representative data being given in Figure 4. Anti-okadaic acid antibodies and lanthanide 
nanoparticles showed diameters of 10.1±1.0 nm and 15.7±2.3 nm, respectively, while 
nanoparticles conjugated to anti-okadaic acid antibodies and labelled with Fab-Alexafluor488 
showed an increase in diameter to 50.8±9.2 nm, and are consistent with AFM data. Upon 
binding of okadaic acid to the antibody a peak maximum was noted at 78.8±7.7 nm, showing 
the gradually increasing hydrodynamic diameter as the complex became larger. 
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The number of antibodies that form a corona around each nanoparticle and held by non-
covalent interactions may be estimated by the equation [25]: 
 
Nmax = 0.65(r3complex - r3nanoparticle)/r3antibody 
 
Considering a hydrodynamic radius for the antibody of 5.05 nm, and close to the IgG (Mw 
~150 kDa) radius of 5.41 nm reported elsewhere [26], a nanoparticle radius of 7.85 nm and 
complex radius of 25.40 nm, the number of antibodies around a nanoparticle is calculated to 
be 83. However, it should be noted that the hydrodynamic radius taken for the antibody does 
not take into consideration the Fab fragment (Mw ~47 kDa, rH = 2.91 nm) bound to the 
antibody Fc region, hence the number of antibody molecules around the nanoparticle would be 
expected to be less than that calculated. In addition, the difference in radius between the 
complex and nanoparticle of 17.55 nm is nearly 2 times the hydrodynamic diameter of the 
antibody alone. Thus, if arrangement of antibodies about the nanoparticle is reasonably 
compact, up to two layers of antibodies may be estimated as surrounding each nanoparticle 
with the layer closest to the nanoparticle estimated as comprising of approximately 10 protein 
molecules based on simple geometrical considerations. As antibodies are more loosely held in 
the outer layer it is possible that there is some exchange with those free in solution. Such 
dynamic exchange is unlikely to affect antibodies immediately bound to the nanoparticle but 
may facilitate the approach of okadaic acid antigen to those more tightly held LRET-enabling 
antibodies at the nanoparticle surface. 
 
For other systems such as ubiquitin (Mw ~8.5 kDa) on 12 nm-diameter gold 
nanoparticles, the orientation of proteins has been shown to be non-random with specific 
domains favoring binding to the nanoparticle [27]. In that work, up to 140 proteins in the 
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protein corona around each nanoparticle was estimated compared to approximately 80 
proteins per corona in the present work although this would be expected considering that 
immunoglobulin IgG has a 17 times greater molecular mass. With respect to the number of 
proteins closely held to the nanoparticle surface, a similar sized protein α-bungarotoxin 
(Mw ~8 kDa) on 20 nm YEuVO4 nanoparticles showed a broad number distribution with a 
maximum for the coupling ratio distribution found for 3 proteins per nanoparticle [28]. From 
simple geometrical considerations, the number of IgG molecules in the near-surface layer in 
the present work was estimated at about 10 molecules per nanoparticle which is similar to the 
value of 7.7 IgG molecules per nanoparticle, based on the value of 2.5 mg IgG m-2 for typical 
monolayer coverage cited elsewhere [29]. 
 
Photoluminescence and fluorescence spectra 
Photoluminescence and fluorescence spectra for the nanoparticle donor and fluorophore 
acceptor are presented in Figure 5. The spectroscopic properties of lanthanide nanoparticles 
derive from f-f transitions in partially filled 4f orbitals which are well shielded by filled 5s and 
5p orbitals. These f-f transitions are forced (induced) electric dipole transitions, i.e. parity 
forbidden, although Laporte’s parity selection rule is relaxed when the lanthanide ion 
becomes influenced by crystal or ligand field interactions [30]. This is particularly relevant 
for Tb3+ ions near the nanoparticle surface which lie in a more asymmetric crystal field, thus 
increasing the transition probability and hence intensity [24]. Doping of nanoparticles with 
cerium was done due to cerium being able to act as a sensitizer because of its ease of 
excitation in the UV region and its quick transfer of energy to an adjacent terbium atom which 
by itself would not be efficiently excited to a resonance level (20430 cm-1; molar absorption 
coefficient typically less than 10 M-1 cm-1) [31]. Further, the use a lanthanum fluoride 
nanoparticle as a rigid host matrix for the cerium ion 'antenna' and terbium ion emitter has an 
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important benefit over using more traditional lanthanide chelates in that the local environment 
is essentially free from high-energy vibrations and the Tb3+ centres are shielded from solvent 
molecules which would efficiently quench luminescence through non-radiative energy 
dissipation by vibronic coupling to the vibrational states of harmonic oscillators such as O-H 
bonds [32]. This, and the large Stokes shift between excitation and emission bands, make 
these doped lanthanide fluoride nanoparticles an appropriate, bright and stable 
photoluminescence source for exciting the organic dye. The trivalent terbium shows two 
emission lines, at 487 nm (5D4 → 7F6) and 544nm (5D4 → 7F5), the former showing excellent 
spectral overlap with the excitation band of AF fluorophore (Figure 5). The emission band of 
AF at 516 nm lies between the emission bands of the lanthanide nanoparticles with relatively 
little overlap hence indicating that this selected donor-acceptor pair is appropriate for 
investigating luminescence resonance energy transfer. 
 
The fluorescence emission spectrum, using an excitation wavelength of 282 nm, was 
recorded for the nanoparticle-antibody-Fab-AF-okadaic acid complex and the intensity ratio of 
the AF emission maximum at 516 nm to the nanoparticle luminescence emission maximum at 
487 nm is given in Figure 6a. For increasing concentrations of okadaic acid the ratio of the 
emission peaks increased, i.e. relative emission from the AF increased while the emission 
from the nanoparticles decreased. Further, to ensure that no components of the complex were 
causing unwanted emission at 516 nm, various configurations were interrogated at an 
excitation wavelength of 282 nm and the spectra are presented in Figure 6b. For the 
nanoparticles alone, nanoparticle-antibody and nanoparticle-antibody-Fab-AF combinations 
essentially no signal was detected at 516 nm while the addition of okadaic acid to the sensor 
caused an increase in emission intensity from the AF at 516 nm.  
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The luminescence resonance energy transfer between donor and acceptor derived from 
antibody-antigen binding is represented schematically in Scheme 1. In the absence of okadaic 
acid antigen, the distance between nanoparticle donor and fluorophore acceptor is too great to 
allow non-radiative energy transfer between the two and hence only the emission band of the 
nanoparticle is seen. Upon addition of okadaic acid and its binding to the antibody based on 
structural complementarity, the change in the spatial orientation of the acceptor with respect 
to the donor was enough to sufficiently reduce the distance between the two and allow 
resonance energy transfer to occur. Since the orientation of the antibody or the goat anti-rabbit 
Fab-conjugated AF had not been expected to change greatly with respect to the nanoparticle in 
the presence of okadaic acid, especially if the antibody corona is reasonably well packed, 
achieving a LRET signal upon antibody-okadaic acid binding indicates that even very minor 
changes in spatial orientation may allow LRET to occur, particularly at donor-acceptor 
distances which border on the range in which LRET may be achieved. 
 
Because of the extreme sensitivity of LRET to distance where energy transfer is 
inversely proportional to the sixth power of the distance between nanoparticle and organic 
dye, and low intensity signals found in this work, it is likely that only labelled antibodies in 
the first coordination sphere of the protein corona are sufficiently close to enable resonance 
energy transfer from the nanoparticle to the acceptor. Considering that the antibodies have a 
hydrodynamic diameter of more than 10 nm, it is likely that the organic dye lay just beyond 
the outer limit of distance over which LRET may occur in the absence of okadaic acid, while 
the addition of okadaic acid may disrupt the spatial configuration of the complex just 
sufficiently to bring the organic dye within distance of the nanoparticle over which energy 
transfer may be expected. 
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  While IgG antibodies comprise of very specific sequences which determine their 
affinity and selectivity towards other macromolecules, the shape of immunoglobulin IgG is 
not rigid but displays great flexibility at the hinge region allowing the two Fab segments to 
move independently. In addition, the ability of the junction of the V (variable) and C 
(constant) domains to rotate and bend provides even more flexibility to the point that it is 
referred to as a molecular 'ball and socket joint'. It is this combined flexibility at the tethered 
Fab arms and V-C junction that plays a key role and likely facilitates sufficient shortening of 
the distance between the donor and acceptor upon antigen binding which results in the 
resonance energy transfer seen here [33]. Further, as energy is transferred only over relatively 
short distances it is not necessary to remove unreacted reagents from the solution thus making 
the measurement a simple and fast 'mix-and-shake' method. 
 
As an alternative scenario, where the binding of the okadaic acid to its antibody results 
in some disruption with the labelled Fab fragment becoming free and then reacting with the 
NP to give resonance energy transfer is not considered likely as the Fab fragment is purposely 
designed to have high specificity and strong attraction for the primary antibody while leaving 
the binding sites of the antibody unhindered. Therefore it would be very unusual for it to 
become free of the primary antibody under the reaction conditions employed in our work. 
Even if such a case did arise and the binding of okadaic acid caused LRET by freeing the Fab-
AF fragment rather than causing LRET due to a slight conformation change of the anti-
okadaic acid antibody, the result would be expected to be qualitatively the same. However, 
there is no evidence that the Fab-AF fragment strongly interacts with the nanoparticles in the 
absence of anti-okadaic acid antibodies (and with or without okadaic acid) as there was no 
fluorescence signal from AF when exciting the nanoparticle thus indicating the lack of 
resonance energy transfer (discussed later in the text).  
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An important aspect to the achieving of LRET was the optimal orientation of antibodies 
on the nanoparticle surface where use of a large excess of ligand created a crowded 
environment which promoted the outward orientation of the bioactive and more hydrophilic 
Fab region. To confirm this, use of ten times less ligand resulted in a sensor showing LRET 
even in the absence of antigen (Figure 6c), clearly indicating that in a less crowded 
environment the antibodies may orient themselves such that their Fab region, and hence also 
the attached goat anti-rabbit Fab-AF fragment, comes sufficiently close to the nanoparticle to 
enable resonance energy transfer. 
 
Lanthanide  transitions have a large energy gap (e.g. 5D4 → 7F0 ΔE=14800cm-1) which 
disfavors non-radiative de-excitation processes and give rise to very long-lived excited states 
with lifetimes on the millisecond scale [34], as also shown in the present work and discussed 
later. Such long life times in time-gating experiments allow the avoidance of signal collection 
from direct excitation of the fluorophore. AlexaFluor488 organic dye has a short fluorescence 
lifetime of ~4 ns allowing separation of direct excitation from nanoparticle-derived excitation 
by simply collecting data more than 4 ns after excitation pulse and as a consequence 
significantly improving signal to noise ratios compared to steady-state illumination 
experiments. This means sensitivity gains that can allow measurements even down to the 
single nanoparticle level [35]. In the present work luminescence lifetime data were collected 
with a 0.1 ms delay after nanoparticle excitation at UV wavelength (Figure 7). Both 
individual nanoparticles and the complex comprising anti-okadaic acid antibody–
nanoparticle–Fab-AF–okadaic acid showed luminescence decays which could be modelled by 
bi-exponential fits by restricting the fitting interval to 0.1–9.7 ms. The fast and slow 
components for nanoparticles alone were found to be 0.59±0.02 and 2.60±0.02 ms 
respectively while the corresponding lifetime values for the complex were 0.37±0.03 and 
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2.10±0.05 ms respectively (fast:slow amplitude ratio of 1:3). Thus the fast component had a 
37% faster decay while the slower component showed a 19% faster decay in the complex 
compared to luminescence lifetimes in the nanoparticles alone. As both time constants 
decreased concomitantly it is therefore not an artefact of the multi-exponential fitting 
procedure, rather enhanced de-excitation. Further, by restricting the time interval from 0.5–
9.7 ms, i.e. collecting data from 0.5 ms after the UV excitation pulse, luminescence lifetimes 
could be modelled by mono-exponential decays that were 0.29 ms faster for the nanoparticle-
containing complex than for nanoparticles alone, again showing enhanced de-excitation of the 
excited nanoparticles when they were part of the antibody-Fab-AF-okadaic acid complex. 
These lifetime data are consistent with data recorded for analogous lanthanide systems such as 
europium chelates and Cy5 organic dye, suggesting that the fast decay component may be 
related to intramolecular energy transfer while the long component is related to the 
nanoparticle donor only [36]. In addition to lack of an AF fluorescence peak from the 
detection complex in the absence of okadaic acid, no shortening of luminescence lifetimes 
was noted for the nanoparticles bound only to antibodies or for nanoparticles bound to Fab-AF 
labelled antibodies. 
 
Analytical performance of the sensor 
The intensity ratio of AF : LaNP emission peaks at 516 nm and 487 nm, respectively, 
with respect to okadaic acid concentration showed an excellent fit (R2 = 0.994) to a sigmoidal 
curve based on the Boltzmann function y = A2 + (A1-A2)/(1+exp((x-x0)/dx)), where A1 was 
0.080, A2 was 0.112, x0 was 1.978 and dx was 0.692, in the okadaic acid concentration 
([OA]) range from 0.25–5.95 μM (Figure 6a). A linear response of the intensity ratio to 
okadaic acid concentration (y = 0.008[OA] + 0.079; R2 = 0.994) was determined for okadaic 
acid in the concentration range from 0.37–3.97 μM (Figure 6a, inset) and a limit of detection 
 16
of 0.25 μM was calculated. In contrast, interrogation of the nanoparticle-antibody-Fab-AF 
complex in the absence of okadaic acid did not result in any fluorophore emission peak at 
516 nm suggesting both that binding of okadaic acid was necessary for resonance energy 
transfer to occur and off-peak excitation of the fluorophore was below the instrumental 
detection limit. In addition, this ratiometric approach offers the advantage that it is essentially 
independent of the absolute concentration of the sensor. 
 
The biosensor was tested on extracts of healthy mussel tissue and only background 
fluorescence was noted (No OA; Figure 8). Fluorescence from extracts of mussel tissue 
contaminated with okadaic acid was also determined and again only low level background 
fluorescence was noted from the crude extracts alone (No sensor; Figure 8). For a mixture of 
OA-contaminated extract and sensor in which the nanoparticle-bound antibody was 
intentionally omitted (i.e. only nanoparticle/Fab-AF mixture present) to test for non-specific 
binding (No antibody; Figure 8). However, the fluorescence intensity ratio (I516/I487) for the 
combined extract and complete biosensor was much greater for various quantities of extracted 
mussel tissue than the two control samples, and the fluorescence intensity ratio increased with 
quantity of okadaic acid extracted from the homogenate. The extract average fluorescence 
intensity ratios for 50 mg, 100 mg and 300 mg homogenates were 23%, 19% and 27% lower 
(after background subtraction) than that expected from the idealized case (Figure 6a) and is 
likely due to the simplified and rapid extraction process used here not achieving maximum 
theoretical 100% okadaic acid retrieval. However, even efficient methods have shown losses 
of more than 18% okadaic acid as an artefact of the extraction process [37]. Thus optimization 
of the extraction method and use of a greater mass of mussel tissue homogenate would be 
expected to increase extraction yield values to greater than 90%. In addition, these 
calculations assume that the certified okadaic acid-contaminated mussel tissue has a 
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homogeneous distribution of okadaic acid throughout the tissue, whereas any inhomogeneity 
would likely give rise to deviations of the sensor response from that theoretically expected. 
However, a high correlation coefficient between the measured and expected values of 0.933 
was noted, the biosensor thereby showing an appropriate fluorescence response with respect 
to increasing okadaic acid concentration in the environmental samples. 
 
Ultimately, sensitivity to very low levels of okadaic acid, as defined by the regulatory 
environment, is one of the most important aspects in the development of biotoxin sensors. In 
this case, the situation is more complex as the current European food safety limit of 
160 μgOA kg-1 shellfish meat (approximately 160 adult mussels yield 1 kg meat, hence 
1 μgOA mussel-1) is several times higher than the acute dose response, so any future reduction 
of the safety limit must be taken into consideration with respect to sensor development. For 
example, a reduced regulatory limit of 40 μgOA kg-1 shellfish meat is the equivalent of 
approximately 250 ngOA per individual mussel and a demonstration of sensitivity to OA at 
levels lower than this is a necessary requirement for the technique to be considered promising. 
In this work, a lower detection limit in the linear response range was calculated to be 
200 ngOA ml-1 (0.25 μM; this mass of okadaic acid being equivalent to 32 μgOA kg-1 
assuming equal quantity of okadaic acid in 160 mussels), a value lower than potential future 
safety limits, suggesting that the technique may be potentially sensitive enough to be applied 
at the individual mussel level. The values in this work also compare favourably with other 
optical biosensors, as for example the recent application of a surface plasmon resonance 
(SPR) biosensor chip for okadaic acid group of toxins gave a slightly lower limit of detection 
of 31 μgOA kg-1 and a sensor working range of 31-174 μgOA kg-1 (equivalent to 0.24-1.36 
μM OA in our system while our linear response range was 0.37-3.97 μM) [17]. However it 
should be noted that the sensor in that work was developed to codetect dinophysistoxin-1 
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(DTX-1), DTX-2 and DTX-3 with okadaic acid, hence the response range would be expected 
to vary from that reported in our work. Other authors have also discussed using SPR based 
techniques for okadaic acid determination and have reported similar working ranges of 2-
2000 μg kg-1 [16] and 20-320 μg kg-1 [38] while the recent application of microfluidics 
devices has enabled the extremely low range of 2-18 nM to be accessed [39], the latter 
showing sensitivity two orders of magnitude greater than our work. 
 
While optical biosensors based on chip technology are becoming increasingly popular, 
much work on biosensors has also been reported over the past number of years on 
demonstrating the ability to generate a FRET signal based on molecular recognition and 
binding. Often, these systems rely on the binding of highly selective moieties with extremely 
high affinity such as the biotin-streptavidin pair to bring donors and acceptors sufficiently 
close to enable resonance energy transfer [40] and [41]. In contrast, this work reports on the 
use of polyclonal antibodies to provide the key recognition and binding step for the optical 
detection of okadaic acid. The use of polyclonal antibodies has disadvantages in some cases, 
particularly lack of specificity issues in multi-parametric assays where there may be unwanted 
cross-reactivity when attempting to distinguish among very similar toxin congeners. In such 
cases more selective monoclonal antibodies or highly selective synthetic oligonucleotide 
sequences (aptamers) may be used [42]. However, from the perspective of determining the 
total toxic potential of a sample, particularly in a regulatory environment, it is less important 
in the first instance to differentiate among toxin congeners which show only minor structural 
variations but still produce the same toxic response. Thus the ability of polyclonal antibodies 
to tolerate minor variations of the 'parent' toxin and bind multiple epitopes may offer a distinct 
advantage in this case. 
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Conclusions 
We have shown for the first time the ability to use simple mix and shake solution 
chemistry based on luminescent nanoparticles and molecular recognition to achieve an optical 
response to the presence of okadaic acid biotoxin. The method does not require sophisticated 
peak deconvolution and may be sufficiently sensitive and versatile to become a 
complementary technique to high performance chromatographic methods for detecting 
biotoxins. Further, the technique is not necessarily limited to the detection of individual toxin 
classes but may be extended to simultaneously detect a range of biotoxin classes. Such a 
multi-parametric sensor may be based on a composite solution of different nanoparticle-dye 
pairs which are reactive towards different biotoxins or by using a single type of nanoparticle 
but with various dyes which give spectral overlap with the different emission lines of the 
nanoparticle, e.g. separate dyes which would overlap with the 490 nm and 540 nm emission 
lines of the lanthanide nanoparticles used in this work. However, much work is still required, 
and in particular a fuller characterization of the system, so as to allow the future rational 
design of such biosensors. For example, determining the specific orientation of the antibodies 
with respect to the nanoparticle and the location of the area of the protein that is binding to the 
nanoparticle will allow better estimation and tailoring of donor-acceptor distances to achieve 
the desired energy transfer process. The technique may ultimately be modified to give greater 
sensitivity towards specific molecules or epitopes within a biotoxin class by using aptamers in 
place of antibodies. However, the nature of the linkage between a labelled aptamer and 
nanoparticle is likely to be crucial, for example a flexible linker is required to allow a 
conformation change (such a conformation change functionality may have to be built into the 
linker) upon binding to the target while too flexible a linker may bring donor and acceptor too 
close giving rise to resonance energy transfer even in the absence of the target molecule. 
Ultimately, these systems show great promise as a new tool not only for food and 
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environmental monitoring, but eventually even in diagnostic tests for other biomolecules of 
interest in human health care. 
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Figures 
 
Figure 1. Powder X-ray diffractogram of dry lanthanide nanoparticles (grey line) and 
fitted pattern (black line) based on a hexagonal LaF3 phase (crystal planes labelled). 
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 Figure 2. AFM images of (a) lanthanide nanoparticles, (b) nanoparticle-antibody 
conjugates and (c) anti-okadaic acid antibodies, with height profiles along indicating lines. 
Images were acquired in tapping mode. 
 
 
 
 
 
Figure 3. Scanning electron micrographs of dehydrated samples of (a) lanthanide 
nanoparticles and (b) nanoparticle-antibody conjugates. Scale bar = 1 μm. 
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 Figure 4. DLS number size distribution for anti-okadaic acid antibodies (Ab), lanthanide 
nanoparticles (LaNP), nanoparticle-antibody-Fab-AF (LaNP+Ab) and nanoparticle-antibody-
Fab-AF-okadaic acid (LaNP+Ab+OA) complexes 
 
 
Figure 5. Excitation (Ex) and emission (Em) spectra of the lanthanide nanoparticle 
(LaNP) donor and AlexaFluor488 (AF) acceptor 
 
 26
  
Figure 6 (a) Ratio of emission intensities for AlexaFluor488 acceptor (I516) and 
lanthanide nanoparticle donor (I487) with increasing okadaic acid (OA) concentration. Inset: 
corresponding fit of data in the linear range. Error bars indicate standard deviations (n=3). (b) 
Emission spectra for various sensor fragments comprising of nanoparticles (LaNP), antibodies 
(Ab), AlexaFluor-labelled Fab (Fab-AF ) and okadaic acid (OA). (c) Emission spectra of the 
LaNP-Ab-Fab-AF sensor in the absence of okadaic acid, where the nanoparticle was 
synthesized with normal (1.0× ligand) and 10 times less (0.1× ligand) amount of o-
phosphorylethanolamine ligand.  
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 Figure 7. Absorption spectra for lanthanide nanoparticles (LaNP; dark line) and 
nanoparticle-antibody-Fab-AF-okadaic acid complex (LaNP+Ab+OA). Inset: luminescence 
decay of LaNP (dark line) and LaNP+Ab+OA after excitation at 266 nm. 
 
 
 
Figure 8. Fluorescence intensity ratio for biosensor-extract mixture for various quantities 
of extracted mussel tissue homogenate. Error bars indicate standard deviations (n=3). 
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 Scheme 1. (a) Excitation and emission from lanthanide nanoparticles (LaNP) decorated 
with Fab-Alexafluor488 (Fab-AF) labelled antibodies in the absence of okadaic acid. (b) 
Luminescence resonance energy transfer between LaNP donor and AF acceptor, and emission 
at longer wavelength, upon okadaic acid-antibody binding. 
 
 
 29
